Alexandria Co. For Pharmaceuticals & Chemical Industries Stock
Stocks
AXPH
EGS38341C011
Pharmaceuticals
|
End-of-day quote
Egyptian Exchange
2026-11-02
|
5-day change | 1st Jan Change | ||
| 1,315.09 EGP | -1.86% |
|
+12.19% | +64.31% |
| Market Cap | 6.58B 119M 106M 97.33M 88.53M 166M 11.25B 169M 1.16B 469M 5.94B 446M 436M 18.75B | P/E 2025 |
5.7x | P/E 2026 | 12x |
|---|---|---|---|---|---|
| Enterprise Value | 6.19B 112M 99.81M 91.59M 83.32M 156M 10.58B 159M 1.09B 441M 5.59B 420M 411M 17.64B | EV / Sales 2025 |
0.71x | EV / Sales 2026 | 1.64x |
| Free-Float |
17.74% | Yield 2025 |
14.1% | Yield 2026 | 5.63% |
| 1 day | -1.86% | ||
| 1 week | +12.19% | ||
| Current month | -5.51% | ||
| 1 month | -12.74% | ||
| 3 months | +5.47% | ||
| 6 months | +44.49% | ||
| Current year | +64.31% |
| 1 week | 1,250 |  | 1,430 |
| 1 month | 1,135 | | 1,550 |
| Current year | 701.66 | | 1,987 |
| 1 year | 701.66 | | 1,987 |
| 3 years | 145.05 | | 1,987 |
| 5 years | 85 | | 1,987 |
| 10 years | 46 | | 1,987 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
Ahmed Fuad
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.86% | +12.19% | +48.98% | +774.22% | 120M | |
| -0.46% | +10.31% | +63.52% | +143.15% | 1,263B | |
| -0.97% | +1.60% | +43.25% | +80.09% | 658B | |
| -2.05% | +0.73% | +32.47% | +101.62% | 521B | |
| -1.54% | +0.18% | +53.42% | +66.79% | 391B | |
| -0.78% | +5.51% | +72.55% | +44.25% | 369B | |
| -1.69% | +3.17% | +32.49% | +55.35% | 307B | |
| -0.72% | +7.83% | +11.15% | +33.76% | 290B | |
| -0.12% | +4.68% | +55.97% | +74.59% | 252B | |
| -0.21% | +7.34% | +42.19% | +109.69% | 212B | |
| Average | -0.97% | +4.96% | +45.60% | +148.35% | 426.2B | |
| Weighted average by Cap. | -0.74% | +5.66% | +49.15% | +93.31% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 2.75B 49.69M 44.37M 40.71M 37.03M 69.43M 4.7B 70.82M 486M 196M 2.48B 187M 183M 7.84B | 3.18B 57.5M 51.33M 47.11M 42.85M 80.34M 5.44B 81.94M 563M 227M 2.87B 216M 211M 9.07B |
| Net income | 391M 7.07M 6.31M 5.79M 5.27M 9.87M 669M 10.07M 69.16M 27.88M 353M 26.52M 25.96M 1.12B | 525M 9.48M 8.46M 7.77M 7.07M 13.25M 898M 13.51M 92.78M 37.4M 474M 35.58M 34.83M 1.5B |
| Net Debt | -282M -5.09M -4.54M -4.17M -3.79M -7.11M -482M -7.25M -49.81M -20.08M -254M -19.1M -18.7M -803M | -387M -7M -6.25M -5.73M -5.22M -9.78M -663M -9.97M -68.49M -27.61M -350M -26.27M -25.71M -1.1B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-02 | EGP 1,315.09 | -1.86% | 3,557 |
| 26-11-01 | EGP 1,340.07 | -3.72% | 3,926 |
| 26-10-29 | EGP 1,391.85 | +3.26% | 3,098 |
| 26-10-28 | EGP 1,347.95 | +6.42% | 4,385 |
| 26-10-27 | EGP 1,266.58 | +8.05% | 2,651 |
- Stock Market
- Stocks
- AXPH Stock
Select your edition
All financial news and data tailored to specific country editions
